nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—breast cancer—Medroxyprogesterone Acetate—uterine cancer	0.195	1	CpDpCtD
Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.158	0.534	CrCtD
Methyltestosterone—Progesterone—uterine cancer	0.138	0.466	CrCtD
Methyltestosterone—CYP19A1—uterine cancer	0.104	1	CbGaD
Methyltestosterone—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.0473	0.307	CbGbCtD
Methyltestosterone—AR—Medroxyprogesterone Acetate—uterine cancer	0.0396	0.256	CbGbCtD
Methyltestosterone—SHBG—Progesterone—uterine cancer	0.0313	0.203	CbGbCtD
Methyltestosterone—AR—Progesterone—uterine cancer	0.0262	0.17	CbGbCtD
Methyltestosterone—Trilostane—Progesterone—uterine cancer	0.0105	0.0493	CrCrCtD
Methyltestosterone—Stanozolol—Progesterone—uterine cancer	0.0088	0.0413	CrCrCtD
Methyltestosterone—Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.00872	0.0409	CrCrCtD
Methyltestosterone—Drostanolone—Progesterone—uterine cancer	0.0076	0.0357	CrCrCtD
Methyltestosterone—Eplerenone—Progesterone—uterine cancer	0.0076	0.0357	CrCrCtD
Methyltestosterone—Oxandrolone—Progesterone—uterine cancer	0.00713	0.0335	CrCrCtD
Methyltestosterone—Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.00693	0.0325	CrCrCtD
Methyltestosterone—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.00693	0.0325	CrCrCtD
Methyltestosterone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.0066	0.031	CrCrCtD
Methyltestosterone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.0066	0.031	CrCrCtD
Methyltestosterone—Formestane—Progesterone—uterine cancer	0.00636	0.0298	CrCrCtD
Methyltestosterone—Drospirenone—Progesterone—uterine cancer	0.00604	0.0283	CrCrCtD
Methyltestosterone—Dydrogesterone—Progesterone—uterine cancer	0.00604	0.0283	CrCrCtD
Methyltestosterone—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.00604	0.0283	CrCrCtD
Methyltestosterone—Spironolactone—Progesterone—uterine cancer	0.00575	0.027	CrCrCtD
Methyltestosterone—Potassium Canrenoate—Progesterone—uterine cancer	0.00575	0.027	CrCrCtD
Methyltestosterone—Medrysone—Medroxyprogesterone Acetate—uterine cancer	0.00557	0.0262	CrCrCtD
Methyltestosterone—Megestrol acetate—Progesterone—uterine cancer	0.00526	0.0247	CrCrCtD
Methyltestosterone—Levonorgestrel—Progesterone—uterine cancer	0.00526	0.0247	CrCrCtD
Methyltestosterone—Danazol—Progesterone—uterine cancer	0.00486	0.0228	CrCrCtD
Methyltestosterone—Medrysone—Progesterone—uterine cancer	0.00486	0.0228	CrCrCtD
Methyltestosterone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.00485	0.0227	CrCrCtD
Methyltestosterone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.0047	0.022	CrCrCtD
Methyltestosterone—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.00468	0.022	CrCrCtD
Methyltestosterone—Hydrocortamate—Progesterone—uterine cancer	0.00423	0.0198	CrCrCtD
Methyltestosterone—Norethindrone—Progesterone—uterine cancer	0.00423	0.0198	CrCrCtD
Methyltestosterone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.00419	0.0197	CrCrCtD
Methyltestosterone—Cortisone acetate—Progesterone—uterine cancer	0.0041	0.0192	CrCrCtD
Methyltestosterone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.00408	0.0192	CrCrCtD
Methyltestosterone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.00408	0.0192	CrCrCtD
Methyltestosterone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00408	0.0192	CrCrCtD
Methyltestosterone—Testolactone—Progesterone—uterine cancer	0.00397	0.0186	CrCrCtD
Methyltestosterone—Fluoxymesterone—Progesterone—uterine cancer	0.00365	0.0171	CrCrCtD
Methyltestosterone—Testosterone Propionate—Progesterone—uterine cancer	0.00356	0.0167	CrCrCtD
Methyltestosterone—Fludrocortisone—Progesterone—uterine cancer	0.00356	0.0167	CrCrCtD
Methyltestosterone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.00354	0.0166	CrCrCtD
Methyltestosterone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00351	0.0228	CbGbCtD
Methyltestosterone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.0156	CrCrCtD
Methyltestosterone—Testosterone—Progesterone—uterine cancer	0.00309	0.0145	CrCrCtD
Methyltestosterone—Prednisolone—Progesterone—uterine cancer	0.00302	0.0142	CrCrCtD
Methyltestosterone—Hydrocortisone—Progesterone—uterine cancer	0.0029	0.0136	CrCrCtD
Methyltestosterone—CYP19A1—corpus luteum—uterine cancer	0.00258	0.211	CbGeAlD
Methyltestosterone—CYP3A4—Progesterone—uterine cancer	0.00233	0.0151	CbGbCtD
Methyltestosterone—CYP2B6—Doxorubicin—uterine cancer	0.00231	0.015	CbGbCtD
Methyltestosterone—SHBG—semen—uterine cancer	0.00149	0.122	CbGeAlD
Methyltestosterone—CYP19A1—semen—uterine cancer	0.00121	0.0989	CbGeAlD
Methyltestosterone—Clotting—Progesterone—uterine cancer	0.00109	0.0591	CcSEcCtD
Methyltestosterone—AR—semen—uterine cancer	0.00107	0.0876	CbGeAlD
Methyltestosterone—CYP3A4—Etoposide—uterine cancer	0.00104	0.00675	CbGbCtD
Methyltestosterone—Clotting—Medroxyprogesterone Acetate—uterine cancer	0.000986	0.0535	CcSEcCtD
Methyltestosterone—AR—oviduct—uterine cancer	0.000785	0.0642	CbGeAlD
Methyltestosterone—Embolism venous—Progesterone—uterine cancer	0.00077	0.0418	CcSEcCtD
Methyltestosterone—CYP3A4—Doxorubicin—uterine cancer	0.00071	0.0046	CbGbCtD
Methyltestosterone—Menstruation irregular—Progesterone—uterine cancer	0.000702	0.0381	CcSEcCtD
Methyltestosterone—Embolism venous—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.0379	CcSEcCtD
Methyltestosterone—Hirsutism—Progesterone—uterine cancer	0.000669	0.0363	CcSEcCtD
Methyltestosterone—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.0345	CcSEcCtD
Methyltestosterone—Hirsutism—Medroxyprogesterone Acetate—uterine cancer	0.000606	0.0329	CcSEcCtD
Methyltestosterone—Oligospermia—Epirubicin—uterine cancer	0.000532	0.0289	CcSEcCtD
Methyltestosterone—Coagulopathy—Progesterone—uterine cancer	0.000499	0.0271	CcSEcCtD
Methyltestosterone—Oligospermia—Doxorubicin—uterine cancer	0.000492	0.0267	CcSEcCtD
Methyltestosterone—Coagulopathy—Medroxyprogesterone Acetate—uterine cancer	0.000452	0.0246	CcSEcCtD
Methyltestosterone—Amenorrhoea—Progesterone—uterine cancer	0.000442	0.024	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Progesterone—uterine cancer	0.000442	0.024	CcSEcCtD
Methyltestosterone—Azoospermia—Epirubicin—uterine cancer	0.000414	0.0225	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.000401	0.0218	CcSEcCtD
Methyltestosterone—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000401	0.0218	CcSEcCtD
Methyltestosterone—Azoospermia—Doxorubicin—uterine cancer	0.000383	0.0208	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Epirubicin—uterine cancer	0.000379	0.0206	CcSEcCtD
Methyltestosterone—Coagulopathy—Dactinomycin—uterine cancer	0.000353	0.0192	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Doxorubicin—uterine cancer	0.000351	0.0191	CcSEcCtD
Methyltestosterone—Libido decreased—Progesterone—uterine cancer	0.000304	0.0165	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Progesterone—uterine cancer	0.000292	0.0158	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Progesterone—uterine cancer	0.00028	0.0152	CcSEcCtD
Methyltestosterone—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.000276	0.015	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.000264	0.0143	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.000254	0.0138	CcSEcCtD
Methyltestosterone—AR—myometrium—uterine cancer	0.000251	0.0206	CbGeAlD
Methyltestosterone—SHBG—endometrium—uterine cancer	0.000246	0.0202	CbGeAlD
Methyltestosterone—SHBG—uterus—uterine cancer	0.000227	0.0186	CbGeAlD
Methyltestosterone—Embolism venous—Epirubicin—uterine cancer	0.000221	0.012	CcSEcCtD
Methyltestosterone—SLCO1A2—renal system—uterine cancer	0.000212	0.0173	CbGeAlD
Methyltestosterone—Embolism venous—Doxorubicin—uterine cancer	0.000204	0.0111	CcSEcCtD
Methyltestosterone—SHBG—female reproductive system—uterine cancer	0.000204	0.0167	CbGeAlD
Methyltestosterone—SLC22A8—renal system—uterine cancer	0.000202	0.0165	CbGeAlD
Methyltestosterone—CYP19A1—endometrium—uterine cancer	0.0002	0.0163	CbGeAlD
Methyltestosterone—AR—epithelium—uterine cancer	0.000197	0.0161	CbGeAlD
Methyltestosterone—Haemoglobin—Progesterone—uterine cancer	0.000196	0.0107	CcSEcCtD
Methyltestosterone—AR—uterine cervix—uterine cancer	0.000195	0.016	CbGeAlD
Methyltestosterone—Haemorrhage—Progesterone—uterine cancer	0.000195	0.0106	CcSEcCtD
Methyltestosterone—AR—smooth muscle tissue—uterine cancer	0.00019	0.0155	CbGeAlD
Methyltestosterone—AR—decidua—uterine cancer	0.000186	0.0152	CbGeAlD
Methyltestosterone—SHBG—female gonad—uterine cancer	0.000186	0.0152	CbGeAlD
Methyltestosterone—SHBG—vagina—uterine cancer	0.000184	0.0151	CbGeAlD
Methyltestosterone—CYP19A1—uterus—uterine cancer	0.000184	0.0151	CbGeAlD
Methyltestosterone—AR—renal system—uterine cancer	0.000183	0.015	CbGeAlD
Methyltestosterone—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000178	0.00965	CcSEcCtD
Methyltestosterone—Angiopathy—Progesterone—uterine cancer	0.000177	0.00962	CcSEcCtD
Methyltestosterone—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000177	0.0096	CcSEcCtD
Methyltestosterone—AR—endometrium—uterine cancer	0.000177	0.0145	CbGeAlD
Methyltestosterone—Alopecia—Progesterone—uterine cancer	0.000173	0.00937	CcSEcCtD
Methyltestosterone—AR—mammalian vulva—uterine cancer	0.000171	0.014	CbGeAlD
Methyltestosterone—CYP19A1—female reproductive system—uterine cancer	0.000165	0.0135	CbGeAlD
Methyltestosterone—AR—uterus—uterine cancer	0.000163	0.0133	CbGeAlD
Methyltestosterone—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000161	0.00871	CcSEcCtD
Methyltestosterone—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000156	0.00849	CcSEcCtD
Methyltestosterone—CYP19A1—female gonad—uterine cancer	0.00015	0.0123	CbGeAlD
Methyltestosterone—Anaphylactoid reaction—Etoposide—uterine cancer	0.000149	0.0081	CcSEcCtD
Methyltestosterone—AR—female reproductive system—uterine cancer	0.000146	0.012	CbGeAlD
Methyltestosterone—Anxiety—Progesterone—uterine cancer	0.000144	0.00783	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Progesterone—uterine cancer	0.000139	0.00753	CcSEcCtD
Methyltestosterone—AR—female gonad—uterine cancer	0.000133	0.0109	CbGeAlD
Methyltestosterone—CYP2B6—renal system—uterine cancer	0.000133	0.0109	CbGeAlD
Methyltestosterone—AR—vagina—uterine cancer	0.000132	0.0108	CbGeAlD
Methyltestosterone—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000131	0.00709	CcSEcCtD
Methyltestosterone—Amenorrhoea—Epirubicin—uterine cancer	0.000127	0.00689	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Epirubicin—uterine cancer	0.000127	0.00689	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000126	0.00682	CcSEcCtD
Methyltestosterone—Paraesthesia—Progesterone—uterine cancer	0.000125	0.00676	CcSEcCtD
Methyltestosterone—Dydrogesterone—PGR—uterine cancer	0.000122	0.0757	CrCbGaD
Methyltestosterone—Alopecia—Dactinomycin—uterine cancer	0.000122	0.00662	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000117	0.00637	CcSEcCtD
Methyltestosterone—Amenorrhoea—Doxorubicin—uterine cancer	0.000117	0.00637	CcSEcCtD
Methyltestosterone—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000113	0.00613	CcSEcCtD
Methyltestosterone—CYP2B6—female reproductive system—uterine cancer	0.000106	0.00869	CbGeAlD
Methyltestosterone—CYP3A4—renal system—uterine cancer	0.0001	0.0082	CbGeAlD
Methyltestosterone—ALB—lymph node—uterine cancer	9.86e-05	0.00807	CbGeAlD
Methyltestosterone—CYP19A1—lymph node—uterine cancer	9.67e-05	0.00792	CbGeAlD
Methyltestosterone—CYP2B6—vagina—uterine cancer	9.6e-05	0.00786	CbGeAlD
Methyltestosterone—Allylestrenol—PGR—uterine cancer	9.52e-05	0.0589	CrCbGaD
Methyltestosterone—Trilostane—ESR2—uterine cancer	9.51e-05	0.0588	CrCbGaD
Methyltestosterone—Angiopathy—Etoposide—uterine cancer	9.06e-05	0.00492	CcSEcCtD
Methyltestosterone—Alopecia—Etoposide—uterine cancer	8.83e-05	0.00479	CcSEcCtD
Methyltestosterone—Headache—Progesterone—uterine cancer	8.69e-05	0.00472	CcSEcCtD
Methyltestosterone—AR—lymph node—uterine cancer	8.56e-05	0.00701	CbGeAlD
Methyltestosterone—Anaphylactoid reaction—Epirubicin—uterine cancer	8.36e-05	0.00454	CcSEcCtD
Methyltestosterone—Nausea—Progesterone—uterine cancer	8.24e-05	0.00447	CcSEcCtD
Methyltestosterone—CYP3A4—female reproductive system—uterine cancer	8.02e-05	0.00656	CbGeAlD
Methyltestosterone—Headache—Medroxyprogesterone Acetate—uterine cancer	7.87e-05	0.00427	CcSEcCtD
Methyltestosterone—Danazol—CCL2—uterine cancer	7.85e-05	0.0485	CrCbGaD
Methyltestosterone—Anaphylactoid reaction—Doxorubicin—uterine cancer	7.74e-05	0.0042	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	7.72e-05	0.0478	CrCbGaD
Methyltestosterone—Nausea—Medroxyprogesterone Acetate—uterine cancer	7.47e-05	0.00405	CcSEcCtD
Methyltestosterone—Etonogestrel—PGR—uterine cancer	7.42e-05	0.0459	CrCbGaD
Methyltestosterone—Megestrol acetate—PGR—uterine cancer	7.36e-05	0.0456	CrCbGaD
Methyltestosterone—Anaphylactic shock—Etoposide—uterine cancer	7.1e-05	0.00385	CcSEcCtD
Methyltestosterone—Testolactone—CYP19A1—uterine cancer	6.81e-05	0.0421	CrCbGaD
Methyltestosterone—Drospirenone—PGR—uterine cancer	6.43e-05	0.0398	CrCbGaD
Methyltestosterone—Paraesthesia—Etoposide—uterine cancer	6.37e-05	0.00346	CcSEcCtD
Methyltestosterone—Drostanolone—CYP19A1—uterine cancer	6.07e-05	0.0376	CrCbGaD
Methyltestosterone—Allylestrenol—ESR1—uterine cancer	6.01e-05	0.0372	CrCbGaD
Methyltestosterone—Trilostane—ESR1—uterine cancer	5.86e-05	0.0362	CrCbGaD
Methyltestosterone—Mestranol—ESR1—uterine cancer	5.86e-05	0.0362	CrCbGaD
Methyltestosterone—Nausea—Dactinomycin—uterine cancer	5.82e-05	0.00316	CcSEcCtD
Methyltestosterone—Haemoglobin—Epirubicin—uterine cancer	5.63e-05	0.00305	CcSEcCtD
Methyltestosterone—Haemorrhage—Epirubicin—uterine cancer	5.6e-05	0.00304	CcSEcCtD
Methyltestosterone—Levonorgestrel—PGR—uterine cancer	5.25e-05	0.0325	CrCbGaD
Methyltestosterone—Haemoglobin—Doxorubicin—uterine cancer	5.21e-05	0.00283	CcSEcCtD
Methyltestosterone—Haemorrhage—Doxorubicin—uterine cancer	5.18e-05	0.00281	CcSEcCtD
Methyltestosterone—Angiopathy—Epirubicin—uterine cancer	5.08e-05	0.00276	CcSEcCtD
Methyltestosterone—Alopecia—Epirubicin—uterine cancer	4.95e-05	0.00269	CcSEcCtD
Methyltestosterone—Danazol—PGR—uterine cancer	4.78e-05	0.0296	CrCbGaD
Methyltestosterone—Angiopathy—Doxorubicin—uterine cancer	4.7e-05	0.00255	CcSEcCtD
Methyltestosterone—Etonogestrel—ESR1—uterine cancer	4.68e-05	0.029	CrCbGaD
Methyltestosterone—Spironolactone—PGR—uterine cancer	4.58e-05	0.0283	CrCbGaD
Methyltestosterone—Alopecia—Doxorubicin—uterine cancer	4.58e-05	0.00248	CcSEcCtD
Methyltestosterone—Ethinyl Estradiol—ESR2—uterine cancer	4.53e-05	0.028	CrCbGaD
Methyltestosterone—Headache—Etoposide—uterine cancer	4.44e-05	0.00241	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—PGR—uterine cancer	4.29e-05	0.0265	CrCbGaD
Methyltestosterone—Norethindrone—PGR—uterine cancer	4.25e-05	0.0263	CrCbGaD
Methyltestosterone—Nausea—Etoposide—uterine cancer	4.21e-05	0.00229	CcSEcCtD
Methyltestosterone—Anxiety—Epirubicin—uterine cancer	4.13e-05	0.00224	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Epirubicin—uterine cancer	3.98e-05	0.00216	CcSEcCtD
Methyltestosterone—Anxiety—Doxorubicin—uterine cancer	3.83e-05	0.00208	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Doxorubicin—uterine cancer	3.68e-05	0.002	CcSEcCtD
Methyltestosterone—Levonorgestrel—CYP19A1—uterine cancer	3.6e-05	0.0223	CrCbGaD
Methyltestosterone—Paraesthesia—Epirubicin—uterine cancer	3.57e-05	0.00194	CcSEcCtD
Methyltestosterone—Levonorgestrel—ESR1—uterine cancer	3.31e-05	0.0205	CrCbGaD
Methyltestosterone—Paraesthesia—Doxorubicin—uterine cancer	3.3e-05	0.00179	CcSEcCtD
Methyltestosterone—Danazol—CYP19A1—uterine cancer	3.28e-05	0.0203	CrCbGaD
Methyltestosterone—Fluoxymesterone—ESR1—uterine cancer	3.16e-05	0.0195	CrCbGaD
Methyltestosterone—Testosterone—CYP11A1—uterine cancer	3.11e-05	0.0192	CrCbGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—YWHAE—uterine cancer	3.07e-05	0.00499	CbGpPWpGaD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.05e-05	0.00497	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—CDKN1B—uterine cancer	3.05e-05	0.00496	CbGpPWpGaD
Methyltestosterone—Danazol—ESR1—uterine cancer	3.02e-05	0.0187	CrCbGaD
Methyltestosterone—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.01e-05	0.0049	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	2.95e-05	0.00481	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—AKR1B1—uterine cancer	2.94e-05	0.00479	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	2.9e-05	0.00472	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—ESR2—uterine cancer	2.83e-05	0.00461	CbGpPWpGaD
Methyltestosterone—AR—FOXA1 transcription factor network—EP300—uterine cancer	2.82e-05	0.00459	CbGpPWpGaD
Methyltestosterone—Ethinyl Estradiol—ESR1—uterine cancer	2.79e-05	0.0173	CrCbGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CDKN2A—uterine cancer	2.79e-05	0.00455	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	2.78e-05	0.00453	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—GPX3—uterine cancer	2.77e-05	0.00451	CbGpPWpGaD
Methyltestosterone—AR—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	2.76e-05	0.0045	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	2.74e-05	0.00446	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.73e-05	0.00445	CbGpPWpGaD
Methyltestosterone—Medroxyprogesterone Acetate—ESR1—uterine cancer	2.71e-05	0.0168	CrCbGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—EP300—uterine cancer	2.67e-05	0.00436	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—STK11—uterine cancer	2.64e-05	0.0043	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	2.64e-05	0.0043	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.6e-05	0.00423	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	2.59e-05	0.00422	CbGpPWpGaD
Methyltestosterone—AR—Nongenotropic Androgen signaling—HRAS—uterine cancer	2.55e-05	0.00416	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	2.55e-05	0.00415	CbGpPWpGaD
Methyltestosterone—Headache—Epirubicin—uterine cancer	2.49e-05	0.00135	CcSEcCtD
Methyltestosterone—Progesterone—PGR—uterine cancer	2.48e-05	0.0153	CrCbGaD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.47e-05	0.00403	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.47e-05	0.00402	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—EP300—uterine cancer	2.43e-05	0.00396	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.41e-05	0.00392	CbGpPWpGaD
Methyltestosterone—Nausea—Epirubicin—uterine cancer	2.36e-05	0.00128	CcSEcCtD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CTNNB1—uterine cancer	2.34e-05	0.0038	CbGpPWpGaD
Methyltestosterone—Headache—Doxorubicin—uterine cancer	2.31e-05	0.00125	CcSEcCtD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	2.27e-05	0.0037	CbGpPWpGaD
Methyltestosterone—AR—Nongenotropic Androgen signaling—AKT1—uterine cancer	2.25e-05	0.00367	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	2.25e-05	0.00366	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	2.2e-05	0.00358	CbGpPWpGaD
Methyltestosterone—Nausea—Doxorubicin—uterine cancer	2.19e-05	0.00119	CcSEcCtD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.19e-05	0.00356	CbGpPWpGaD
Methyltestosterone—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	2.17e-05	0.00353	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—AKR1C1—uterine cancer	2.16e-05	0.00352	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.11e-05	0.00344	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	2.04e-05	0.00332	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.97e-05	0.00321	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.97e-05	0.00321	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.96e-05	0.00319	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—GPX3—uterine cancer	1.9e-05	0.00309	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	1.88e-05	0.00307	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	1.88e-05	0.00306	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.88e-05	0.00306	CbGpPWpGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	1.86e-05	0.00303	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PHF1—uterine cancer	1.84e-05	0.003	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—MTHFR—uterine cancer	1.79e-05	0.00291	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	1.78e-05	0.00291	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.78e-05	0.00291	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.78e-05	0.00291	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	1.76e-05	0.00287	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	1.76e-05	0.00287	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	1.75e-05	0.00285	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	1.73e-05	0.00282	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	1.73e-05	0.00281	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	1.72e-05	0.0028	CbGpPWpGaD
Methyltestosterone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	1.71e-05	0.00279	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	1.68e-05	0.00274	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	1.66e-05	0.00271	CbGpPWpGaD
Methyltestosterone—Testosterone—CYP19A1—uterine cancer	1.61e-05	0.00994	CrCbGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—EP300—uterine cancer	1.6e-05	0.00261	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—CHD4—uterine cancer	1.57e-05	0.00255	CbGpPWpGaD
Methyltestosterone—Progesterone—ESR1—uterine cancer	1.56e-05	0.00968	CrCbGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	1.53e-05	0.0025	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.53e-05	0.00249	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	1.52e-05	0.00247	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.46e-05	0.00238	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.45e-05	0.00236	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	1.44e-05	0.00234	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	1.42e-05	0.00231	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—CCL2—uterine cancer	1.4e-05	0.00228	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.39e-05	0.00226	CbGpPWpGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.37e-05	0.00223	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—PGR—uterine cancer	1.36e-05	0.00221	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	1.34e-05	0.00218	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.33e-05	0.00217	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	1.32e-05	0.00215	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	1.31e-05	0.00214	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—SUZ12—uterine cancer	1.31e-05	0.00214	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	1.31e-05	0.00214	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.31e-05	0.00213	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	1.3e-05	0.00211	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SRD5A2—uterine cancer	1.22e-05	0.00198	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NDUFB11—uterine cancer	1.22e-05	0.00198	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—ESR2—uterine cancer	1.2e-05	0.00195	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.19e-05	0.00195	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.18e-05	0.00192	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.13e-05	0.00184	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.12e-05	0.00183	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.12e-05	0.00182	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	1.11e-05	0.00181	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.1e-05	0.0018	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.1e-05	0.0018	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SRD5A2—uterine cancer	1.1e-05	0.00179	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NDUFB11—uterine cancer	1.1e-05	0.00179	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.07e-05	0.00175	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.07e-05	0.00174	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.05e-05	0.00171	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.05e-05	0.0017	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	1.02e-05	0.00167	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.01e-05	0.00164	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	9.96e-06	0.00162	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	9.92e-06	0.00162	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	9.81e-06	0.0016	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	9.73e-06	0.00159	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	9.73e-06	0.00159	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	9.7e-06	0.00158	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	9.7e-06	0.00158	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9.64e-06	0.00157	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9.64e-06	0.00157	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	9.49e-06	0.00155	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	9.37e-06	0.00153	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	9.17e-06	0.00149	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	9.13e-06	0.00149	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	9.05e-06	0.00147	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—SMAD3—uterine cancer	8.88e-06	0.00145	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—AKR1B1—uterine cancer	8.79e-06	0.00143	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—STAR—uterine cancer	8.79e-06	0.00143	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.71e-06	0.00142	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.69e-06	0.00142	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	8.61e-06	0.0014	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	8.57e-06	0.0014	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	8.47e-06	0.00138	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	8.25e-06	0.00134	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	8.11e-06	0.00132	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	8e-06	0.0013	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—STAR—uterine cancer	7.94e-06	0.00129	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—AKR1B1—uterine cancer	7.94e-06	0.00129	CbGpPWpGaD
Methyltestosterone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	7.93e-06	0.00129	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFA—uterine cancer	7.7e-06	0.00125	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	7.55e-06	0.00123	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	7.52e-06	0.00123	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	7.34e-06	0.00119	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	7.28e-06	0.00119	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—ESR1—uterine cancer	7.25e-06	0.00118	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.08e-06	0.00115	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SRD5A2—uterine cancer	7.06e-06	0.00115	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NDUFB11—uterine cancer	7.06e-06	0.00115	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.01e-06	0.00114	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—POLD1—uterine cancer	6.9e-06	0.00112	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—uterine cancer	6.79e-06	0.00111	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PGR—uterine cancer	6.54e-06	0.00106	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	6.47e-06	0.00105	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—AKR1C1—uterine cancer	6.45e-06	0.00105	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.44e-06	0.00105	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	6.35e-06	0.00103	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.23e-06	0.00102	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—POLD1—uterine cancer	6.23e-06	0.00102	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—EZH2—uterine cancer	6.21e-06	0.00101	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	5.97e-06	0.000972	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IRF1—uterine cancer	5.95e-06	0.00097	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NDUFB11—uterine cancer	5.94e-06	0.000968	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SRD5A2—uterine cancer	5.94e-06	0.000968	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	5.88e-06	0.000959	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—AKR1C1—uterine cancer	5.83e-06	0.00095	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.77e-06	0.00094	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ESR2—uterine cancer	5.76e-06	0.000938	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—RRM2—uterine cancer	5.75e-06	0.000937	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—DCN—uterine cancer	5.58e-06	0.000909	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	5.47e-06	0.000891	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.45e-06	0.000887	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.26e-06	0.000858	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP11A1—uterine cancer	5.26e-06	0.000857	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—RRM2—uterine cancer	5.2e-06	0.000846	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—AKR1B1—uterine cancer	5.1e-06	0.000831	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—STAR—uterine cancer	5.1e-06	0.000831	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—DCN—uterine cancer	5.04e-06	0.000822	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—AKR1C3—uterine cancer	4.97e-06	0.000809	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP11A1—uterine cancer	4.75e-06	0.000774	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—CDKN2B—uterine cancer	4.68e-06	0.000763	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—AKR1C3—uterine cancer	4.49e-06	0.000731	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—AKR1B1—uterine cancer	4.29e-06	0.000699	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—STAR—uterine cancer	4.29e-06	0.000699	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—SMAD3—uterine cancer	4.28e-06	0.000697	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.24e-06	0.000691	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—POLD1—uterine cancer	4e-06	0.000652	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP19A1—uterine cancer	3.87e-06	0.00063	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—STK11—uterine cancer	3.87e-06	0.00063	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—AKR1C1—uterine cancer	3.74e-06	0.00061	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.63e-06	0.000592	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—STK11—uterine cancer	3.5e-06	0.00057	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ESR1—uterine cancer	3.49e-06	0.000569	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.46e-06	0.000564	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	3.42e-06	0.000556	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—POLD1—uterine cancer	3.37e-06	0.000549	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—RRM2—uterine cancer	3.34e-06	0.000544	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.28e-06	0.000535	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—DCN—uterine cancer	3.24e-06	0.000528	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.21e-06	0.000522	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.21e-06	0.000522	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—AKR1C1—uterine cancer	3.15e-06	0.000513	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.13e-06	0.00051	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP11A1—uterine cancer	3.05e-06	0.000497	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—MTHFR—uterine cancer	2.91e-06	0.000474	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—AKR1C3—uterine cancer	2.88e-06	0.00047	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—RRM2—uterine cancer	2.81e-06	0.000458	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—DCN—uterine cancer	2.73e-06	0.000444	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.67e-06	0.000435	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—MTHFR—uterine cancer	2.63e-06	0.000428	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP11A1—uterine cancer	2.57e-06	0.000419	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.56e-06	0.000417	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—AKR1C3—uterine cancer	2.43e-06	0.000395	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—STAR—uterine cancer	2.32e-06	0.000378	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.32e-06	0.000378	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.32e-06	0.000377	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP19A1—uterine cancer	2.25e-06	0.000366	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—STK11—uterine cancer	2.25e-06	0.000366	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.18e-06	0.000355	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—STK11—uterine cancer	1.89e-06	0.000308	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP19A1—uterine cancer	1.89e-06	0.000308	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—EP300—uterine cancer	1.86e-06	0.000303	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—POLD1—uterine cancer	1.82e-06	0.000296	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.77e-06	0.000289	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—uterine cancer	1.76e-06	0.000287	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—NRAS—uterine cancer	1.74e-06	0.000283	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.7e-06	0.000277	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.69e-06	0.000276	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—MTHFR—uterine cancer	1.69e-06	0.000275	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTEN—uterine cancer	1.62e-06	0.000263	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—EP300—uterine cancer	1.54e-06	0.000251	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—RRM2—uterine cancer	1.52e-06	0.000247	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—KRAS—uterine cancer	1.5e-06	0.000244	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—DCN—uterine cancer	1.47e-06	0.00024	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTEN—uterine cancer	1.46e-06	0.000238	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—MTHFR—uterine cancer	1.42e-06	0.000231	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—EP300—uterine cancer	1.39e-06	0.000227	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.39e-06	0.000226	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CA—uterine cancer	1.37e-06	0.000224	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—uterine cancer	1.33e-06	0.000217	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.31e-06	0.000213	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—HRAS—uterine cancer	1.27e-06	0.000207	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—AKT1—uterine cancer	1.26e-06	0.000205	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.25e-06	0.000204	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CA—uterine cancer	1.14e-06	0.000186	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—AKT1—uterine cancer	1.12e-06	0.000183	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CA—uterine cancer	1.03e-06	0.000168	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—STK11—uterine cancer	1.02e-06	0.000166	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.02e-06	0.000166	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTEN—uterine cancer	9.39e-07	0.000153	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—AKT1—uterine cancer	9.32e-07	0.000152	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—EP300—uterine cancer	8.95e-07	0.000146	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—AKT1—uterine cancer	8.42e-07	0.000137	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTEN—uterine cancer	7.9e-07	0.000129	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—MTHFR—uterine cancer	7.67e-07	0.000125	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—EP300—uterine cancer	7.54e-07	0.000123	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CA—uterine cancer	6.62e-07	0.000108	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CA—uterine cancer	5.57e-07	9.08e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—AKT1—uterine cancer	5.41e-07	8.81e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—AKT1—uterine cancer	4.55e-07	7.42e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTEN—uterine cancer	4.27e-07	6.95e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—EP300—uterine cancer	4.07e-07	6.63e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.01e-07	4.9e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—AKT1—uterine cancer	2.46e-07	4e-05	CbGpPWpGaD
